Cumberland Pharmaceuticals CPIX Geographic — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Cumberland Pharmaceuticals’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's geographic — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's geographic — revenue?
- Cumberland Pharmaceuticals (CPIX) reported geographic — revenue of $1.23M in Q4 2025.
- How has Cumberland Pharmaceuticals's geographic — revenue changed year-over-year?
- Cumberland Pharmaceuticals's geographic — revenue increased by 81.5% year-over-year, from $675K to $1.23M.
- What is the long-term trend for Cumberland Pharmaceuticals's geographic — revenue?
- Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's geographic — revenue has grown at a 22.2% compound annual growth rate (CAGR), from $2.2M to $4.9M.
- What does geographic — revenue mean?
- This metric represents the total gross sales generated from pharmaceutical products sold in geographic markets outside of the company's primary domestic territory. It serves as a key indicator of the company's international market penetration and the scalability of its product portfolio in foreign regulatory environments. Tracking this revenue stream helps investors assess the diversification of the company's geographic footprint and its success in navigating global healthcare distribution channels.